Viewing Study NCT03641950


Ignite Creation Date: 2025-12-24 @ 5:04 PM
Ignite Modification Date: 2026-01-04 @ 3:25 AM
Study NCT ID: NCT03641950
Status: COMPLETED
Last Update Posted: 2018-08-22
First Post: 2018-08-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Objective of This Study is to Evaluate the Efficacy and Safety of Botulax® in Patients With Essential Blepharospasm.
Sponsor: Hugel
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module